sglt2 glp-1 news Renal outcomes of inhibitors and GLP1 agonists in clinical practice SGLT2 vs GLP-1 for CKD:

Healthy weight loss aims to reduce adipose tissue while preserving metabolically active muscle

doi: 10.1016/j.ecl.2013.07.002 [PubMed] 26696689 American Diabetes Association

DAO breaks down histamine from food in the gut, while HNMT breaks down histamine produced by the bodys own cells, especially in the brain

[PubMed] [Google Scholar] 12.Fisher R.F

Spironolactone-driven nocturia is mechanistically different from overactive bladder, but increased functional bladder capacity still reduces waking frequency

Step therapy restrictions reduce first-year prescription capture by 30-50% for drugs placed below step-one, making step-one status a primary market access negotiating objective